Table 1.
Summary of the included comparative studies. Abbreviations: β-TCP, beta-tricalcium phosphate; CG, control group; CT, clinical trial; DBB, deproteinized bovine bone; HBA, horizontal bone augmentation; LMSA, lateral maxillary sinus augmentation; PRP, platelet-rich plasma; RCT, randomized clinical trial; TG, test group; TSL, transcrestal sinus lift.
| Author | Country | Type of Study | N Control | N Test | Control Material | Test Material | Procedure | Follow-up (months) | Survival Rate (Implant Failures) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | Implants | Patients | Implants | ||||||||
| Steigmann et al., 2005 [29] | USA | Split mouth RCT | 20 | Not specified | 20 | Not Specified | PRP | β-TCP | LMSA or TSL | 6 | 100% (0) |
| Uckan et al., 2010 [25] | Turkey | CT | 65 | 136 | 62 | 121 | Alveolar ridge | β-TCP | LMSA | CG 32.3; TG 29.8 |
CG 99.26% (1); TG 99.17% (1) |
| Daif et al., 2013 [26] | Egypt | RCT | 14 | 14 | 14 | 14 | Blood clot | β-TCP | Immediate implants | 6 after loading | 100% (0) |
| Trombelli et al., 2014 [27] | Italy | RCT | 19 | 19 | 19 | 19 | DBB | β-TCP | TSL | 6 | 100% (0) |
| Markovic et al., 2016 [28] | Serbia | RCT | 45 | 45 | 45 | 135 (45 every test group) | Blood clot | T1 β-TCP; T2 DBB; T3 β-TCP+DBB | TSL | 24 after loading | 100% (0) |
| Merli et al., 2018 [30] | Italy | RCT | 18 | 23 | 14 | 16 | DBB | β-TCP | HBA | 36 after loading | 100% (0) |